Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine
State of Palestine: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.0% in 2024. ◆ Volatile
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine, 2015–2024
Source: United Nations Statistics Division, SDG Global Database. Measured in %.
Analysis
The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine is 0.0%, measured in 2024. That is the lowest value across all 10 years on record.
The figure is down 100.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2017.
State of Palestine ranks 167th of 246 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in State of Palestine, year by year
| Year | % | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.0% | -100.0% |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 0.0% | — |
| 2022 | 0.0% | — |
| 2023 | 0.0% | — |
| 2024 | 0.0% | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.1% | 5 |
| 2020s | 0.0% | 0.0% | 0.0% | 5 |
Countries ranked near State of Palestine
- 167 Andorra 0.0%
- 167 Argentina 0.0%
- 167 Austria 0.0%
- 167 Bahrain 0.0%
- 167 Belarus 0.0%
- 167 Belgium 0.0%
- 167 Bermuda 0.0%
- 167 Brazil 0.0%
- 167 Bulgaria 0.0% compare
- 167 Canada 0.0%
- 167 Chile 0.0%
- 167 Colombia 0.0%
- 167 Cook Islands 0.0%
- 167 Costa Rica 0.0%
- 167 Croatia 0.0%
- 167 Cuba 0.0%
- 167 Czechia 0.0%
- 167 Ecuador 0.0%
- 167 Egypt 0.0% compare
- 167 El Salvador 0.0%
- 167 Estonia 0.0%
- 167 Falkland Islands (Malvinas) 0.0%
- 167 Faroe Islands 0.0% compare
- 167 Finland 0.0%
- 167 France 0.0%
- 167 French Guiana 0.0%
- 167 French Polynesia 0.0% compare
- 167 Georgia 0.0%
- 167 Germany 0.0%
- 167 Gibraltar 0.0%
- 167 Greece 0.0%
- 167 Greenland 0.0%
- 167 Guatemala 0.0% compare
- 167 Guernsey 0.0% compare
- 167 Holy See 0.0%
- 167 Honduras 0.0%
- 167 Iceland 0.0% compare
- 167 Iran (Islamic Republic of) 0.0%
- 167 Ireland 0.0%
- 167 Isle of Man 0.0% compare
- 167 Italy 0.0%
- 167 Japan 0.0% compare
- 167 Jersey 0.0% compare
- 167 Kuwait 0.0%
- 167 Latvia 0.0% compare
- 167 Liechtenstein 0.0%
- 167 Luxembourg 0.0%
- 167 Malta 0.0% compare
- 167 Mexico 0.0%
- 167 Monaco 0.0%
- 167 Montenegro 0.0%
- 167 Morocco 0.0%
- 167 Netherlands (Kingdom of the) 0.0%
- 167 New Zealand 0.0% compare
- 167 Nicaragua 0.0% compare
- 167 Niue 0.0%
- 167 Norway 0.0% compare
- 167 Panama 0.0%
- 167 Poland 0.0%
- 167 Portugal 0.0%
- 167 Qatar 0.0% compare
- 167 Republic of Korea 0.0% compare
- 167 Saint Pierre and Miquelon 0.0%
- 167 San Marino 0.0%
- 167 Saudi Arabia 0.0%
- 167 Slovakia 0.0%
- 167 Slovenia 0.0% compare
- 167 Spain 0.0%
- 167 Sweden 0.0%
- 167 Switzerland 0.0% compare
- 167 Tokelau 0.0%
- 167 Türkiye 0.0% compare
- 167 United Arab Emirates 0.0%
- 167 United Kingdom of Great Britain and Northern Ireland 0.0% compare
- 167 Uruguay 0.0%
- 167 Republic of Korea 0.0% compare
- 167 Türkiye 0.0% compare
- 167 United Kingdom of Great Britain and Northern Ireland 0.0% compare
- 167 United States of America 0.0%
More development goals data for State of Palestine
- Red List Index 0.8274 index (2025)
- Number of refugees per 100,000 population, by country of origin 825.09 per 100,000 people (2025)
- Manufacturing value added per capita 366.44 constant US$ (2025)
- Number of transboundary breeds 4 (2025)
- Number of transboundary breeds (not extinct) 4 (2025)
- Number of transboundary breeds with unknown risk status 0 (2025)
- Number of local breeds (not extinct) 2 (2025)
- Number of local breeds with unknown risk status 0 (2025)
- Number of local breeds kept in the country 2 (2025)
- Children moderately or severely overweight 63.2 num th (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in State of Palestine was 0.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in State of Palestine?
- The highest recorded value was 0.1% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in State of Palestine?
- The lowest recorded value was 0.0% in 2017.
- How does State of Palestine rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- State of Palestine ranks 167th out of 246 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in State of Palestine?
- Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
- Where does this State of Palestine data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).